2007
DOI: 10.1071/wrv34n7_in
|View full text |Cite
|
Sign up to set email alerts
|

Introduction - virally vectored immunocontraception in Australia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 31 publications
0
10
0
Order By: Relevance
“…Criticism of this approach raised concerns regarding its irreversibility, the difficulty of controlling the vectors once released, possible mutations of the vectors that could affect non-target species and possible development of population resistance to these vectors (e.g. Barlow 2000;Tyndale-Biscoe and Hinds 2007;Williams 2007). For these reasons, none of these systems has been approved for field studies.…”
Section: Delivery Methodsmentioning
confidence: 99%
“…Criticism of this approach raised concerns regarding its irreversibility, the difficulty of controlling the vectors once released, possible mutations of the vectors that could affect non-target species and possible development of population resistance to these vectors (e.g. Barlow 2000;Tyndale-Biscoe and Hinds 2007;Williams 2007). For these reasons, none of these systems has been approved for field studies.…”
Section: Delivery Methodsmentioning
confidence: 99%
“…Despite concerted efforts over 10-15 years for mice, rabbits and foxes, technical difficulties precluded the full development of species-specific VVIC vaccines for field release. [95] Nevertheless, the approach still offers an excellent promise as a disseminating or non-disseminating delivery system for immunocontraceptive antigens to pest mammals.…”
Section: Formulation Of Non-living Vaccinesmentioning
confidence: 99%
“…The speciestailoring process can either be achieved through the vaccinecompound itself or the delivery method. Examples of the former include vectored immunocontraception for foxes, rabbits and mice (McLeod et al 2007;Redwood et al 2007;Strive et al 2007;Tyndale-Biscoe and Hinds 2007;Van Leeuwen and Kerr 2007) or the University of Newcastle's phage bio-panning technique (Aitken 2006). Current orally deliverable actives being investigated, such as GnRH or VCD will, however, require specificity in their respective delivery methods.…”
Section: The Species-tailoring Processmentioning
confidence: 99%